Implementation and Cross-Validation of a Pharmacokinetic Model for Precision Dosing of Busulfan in Hematopoietic Stem Cell Transplanted Children
Busulfan, a drug used in conditioning prior to hematopoietic stem cell transplantation (HSCT) in children, has a narrow therapeutic margin. The model-informed precision dosing (MIPD) of busulfan is desirable, but there is a lack of validated tools. The objective of this study was to implement and cr...
Saved in:
Main Authors: | Sylvain Goutelle (Author), Yann Thoma (Author), Roxane Buffet (Author), Michael Philippe (Author), Thierry Buclin (Author), Monia Guidi (Author), Chantal Csajka (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
From Personalized to Precision Medicine in Oncology: A Model-Based Dosing Approach to Optimize Achievement of Imatinib Target Exposure
by: Sylvain Goutelle, et al.
Published: (2023) -
Precision dosing of intravenous busulfan in pediatric hematopoietic stem cell transplantation: Results from a multicenter population pharmacokinetic study
by: Khalil Ben Hassine, et al.
Published: (2021) -
The Steps to Therapeutic Drug Monitoring: A Structured Approach Illustrated With Imatinib
by: Thierry Buclin, et al.
Published: (2020) -
Population Pharmacokinetics in Oncology and Its Clinical Applications
by: Nicolas Widmer, et al.
Published: (2024) -
External Evaluation of Population Pharmacokinetic Models of Busulfan in Chinese Adult Hematopoietic Stem Cell Transplantation Recipients
by: Huiping Huang, et al.
Published: (2022)